Sign Up to like & get
recommendations!
1
Published in 2018 at "Leukemia"
DOI: 10.1038/s41375-018-0224-8
Abstract: Among the driver mutations in the MPNs, the mechanism by which CALR mutations activate JAK/STAT signaling is unique in that the novel C-terminus of CALR mutant proteins binds directly to MPL leading to constitutive activation…
read more here.
Keywords:
calr;
akt activation;
calr mutant;
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood Cancer Journal"
DOI: 10.1038/s41408-018-0166-4
Abstract: Mutations in exon 9 of the calreticulin gene (CALR) frequently occur in patients with chronic myeloproliferative neoplasms (MPN). Patients exhibit spontaneous cellular immune responses to epitopes derived from the mutant CALR C-terminus, and CALR-mutant-specific T…
read more here.
Keywords:
healthy individuals;
memory cells;
calr mutant;
calr ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Hematology"
DOI: 10.1080/16078454.2022.2107888
Abstract: ABSTRACT Objective Calreticulin (CALR) mutations have been identified as driver mutations in a quarter of patients with essential thrombocythaemia (ET) and primary myelofibrosis (PMF), which are subgroups of myeloproliferative neoplasms (MPNs). A 52-bp deletion (type…
read more here.
Keywords:
type type;
overt pmf;
myelofibrosis;
calr mutant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood"
DOI: 10.1182/blood.2022015629
Abstract: Calreticulin (CALR) mutations are important disease-initiating drivers of myeloproliferative neoplasms (MPNs) and cause hyperproliferation by binding to the thrombopoietin (TPO) receptor and inducing cytokine independent signaling. Jutzi and colleagues report on a CRISPR knockout screen…
read more here.
Keywords:
calr;
genome crispr;
glycosylation;
calr mutant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12112570
Abstract: Somatic CALR mutations occur in approximately 70% of patients with JAK2 V617F-negative essential thrombocythemia (ET) and primary myelofibrosis (PMF). We evaluated the effects of the CALR mutant type and burden on the phenotype of CALR-mutated…
read more here.
Keywords:
phenotype;
mutant type;
type like;
calr mutant ... See more keywords